Latest news
Trump's 2028 Generic Drug Tariff Plan Signals New Phase in U.S. Pharmaceutical Onshoring Push - Energy Earnings Report - dars.gov.etdars.gov.et · Mon, 03 Aug 2026 06:07:46 GMTTrump's Generic Drug Tariff Plan Set for 2028, Testing U.S. Onshoring Push - Tech Earnings Analysis - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 22:06:48 GMTTrump's Proposed 2028 Generic Drug Tariffs Signal Two-Year Window for U.S. Onshoring Push - EBITDA Estimate Trend - dars.gov.etdars.gov.et · Sun, 02 Aug 2026 02:01:51 GMTTrump's 2028 Generic Drug Tariffs: Two-Year Delay Challenges U.S. Onshoring Push - Free Cash Flow Trends - dars.gov.etdars.gov.et · Sat, 01 Aug 2026 07:00:00 GMTTrump Proposes Tariffs on Generic Drugs Starting 2028, Signaling Onshoring Push with Two-Year Delay - Dividend Increase Stocks - dars.gov.etdars.gov.et · Wed, 29 Jul 2026 13:14:10 GMTTrump’s Proposed Generic Drug Tariffs from 2028 Signal Bold Onshoring Push but Face Hurdles - Negative Surprise Momentum - dars.gov.etdars.gov.et · Mon, 27 Jul 2026 18:24:44 GMTTrump’s Proposed Generic Drug Tariffs from 2028 Signal Bold Onshoring Push but Face Hurdles - Estimate Accuracy - dars.gov.etdars.gov.et · Mon, 27 Jul 2026 07:00:00 GMT